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Mesenchymal stem cells have been investigated as an alternative source of 
osteogenic cells for the repair of large bone defects. Previously, a more 
homogeneous population of human mesenchymal stem cells (hMSCs) was identified 
that showed enhanced osteogenic potential in vitro. The cells were isolated by the 
relative expression of Runx2 compared to Sox9. In this study, it was investigated if 
these sorted cells based on their Runx2/Sox9 ratio can improve bone healing in vivo 
in a nude rat calvarial defect model.  
Five millimeter bone defects were generated and filled with either sorted or unsorted 
cells, both seeded on a collagen membrane, or with the membrane only. In vivo CT 
analysis was carried out post OP, 2 weeks after surgery and after euthanasia 4 
weeks post OP to show bone ingrowth into the defect. The fluorochrome Xylenol 
Orange was used for labeling bone formation after 3 weeks and all samples were 
analyzed histologically for bone formation and inflammation. 
Neither the CT nor the histological results led to a statistically significant difference 
between the 3 groups, but the control group (membrane only) trended towards 
producing the most new bone, especially after 2 weeks. This may suggest that the 
seeded cells impair bone healing. A possible reason for this could be a rejection 
triggered in response to the hMSCs, despite the lack of T cells in nude rats. Further 





Mesenchymale Stammzellen werden als alternative Quelle für osteogene Zellen zur 
Reparatur großer Knochendefekte untersucht. Aktuell wurde eine homogenere 
Population von humanen mesenchymalen Stammzellen (hMSCs) identifiziert, die in 
vitro ein erhöhtes osteogenes Potential zeigten. Die Zellen wurden durch die relative 
Expression von Runx2 im Vergleich zu Sox9 isoliert. In dieser Studie wurde 
untersucht, ob diese nach ihrem Runx2/Sox9-Verhältnis sortierten Zellen die 
Knochenheilung in vivo in einem Schädelkalottendefektmodell in Nacktratten 
verbessern können. 
Fünf Millimeter Knochendefekte wurden mit sortierten oder unsortierten Zellen, 
jeweils auf einer Kollagenmembran gesät oder nur mit der Membran gefüllt. Die 
Knochenbildung im Defekt wurde mit CT Aufnahmen post OP, nach 2 Wochen und 
nach Euthanasie 4 Wochen post OP dargestellt. Das Fluorochrom Xylenolorange 
wurde zur Markierung der Knochenbildung nach 3 Wochen verwendet. Histologisch 
wurde die Knochenbildung und Entzündung analysiert. 
Weder in der CT-Analyse noch in der Histologie wurde zwischen den 3 Gruppen ein 
statistisch signifikanter Unterschied beobachtet, jedoch schien die Gruppe mit nur der 
Membran v.a. nach 2 Wochen tendenziell mehr Knochen zu bilden. Dies könnte 
darauf hindeuten, dass die Anwesenheit von Zellen die Knochenheilung 
beeinträchtigen. Ein möglicher Grund dafür könnte eine Abstossungsreaktion auf die 
hMSCs sein, trotz des T-Zell Mangels in Nacktratten. Weitere Studien sind zur 





2.1 Clinical problem 
Serious high-energy accidents, resections of bone tumors or cysts, revision surgeries 
of non-healing fractures (nonunion), joint implant loosening and the treatment of bone 
infections can lead to large bone defects whose treatment is often complicated and 
difficult.฀1 
More than two million bone grafting procedures are carried out worldwide annually.฀2 
A bone graft with autologous bone is still the gold standard for the repair of large 
bone defects.฀3 The advantage of this method is that the filling material has all the 
important properties for bone regeneration, since autologous bone graft is both 
osteoconductive and osteoinductive and also contains osteogenic cells therefore 
representing the ideal treatment.฀3–5 
However, the amount of autologous bone available is limited and the complication 
rate (blood loss, hematoma formation, infections, pain at the removal site) is up to 
20%.฀6, 7  
2.2 Bone-graft substitutes 
Bone-graft substitutes can either be used in place of an autograft or expand the 
existing amount of an autologous bone graft.฀5, 8 Kolk et al described the ideal bone 
graft substitute as biocompatible, bioresorbable, osteoconductive, osteoinductive, 
structurally similar to bone, easy to use and cost-effective.฀3 Bone graft substitutes are 
known as important alternatives to bone grafting in dental surgery, implantology and 
periodontology.฀3 As an alternative to autologous bone, allogeneic (from same 
species) or even xenogeneic (from a different species) bone can be used. 
Nevertheless, there is a risk of a rejection reaction or transmission of diseases (HIV, 
zoonosis, etc.). Due to these limitations, new bone graft substitutes are being 
investigated, which have unlimited availability, are inexpensive and have similar 
characteristics as autologous bone grafts. 
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Nandi et al ฀8 modified the Laurencin et al ฀9 classification of grafts and graft 
substitutes as shown in this overview: 
Table 1: Bone grafts and graft substitutes 
Class Description Examples 




Autologous bone marrow 




Allogenic bone marrow 
Demineralized bone matrix (DBM) 
Factor based Natural and 
recombinant 
growth factors 
used alone or in 
combination with 
other materials 
Transforming growth factor beta (TGFβ)  
Basic fibroblast growth factor (bFGF)  
Platelet derived growth factor (PDGF)  
Bone morphogenetic proteins (BMPs) 
Insulin like growth factor (IGF-1)  
Vascular endothelial growth factor (VEGF) 
Cell based Cells to generate 
new tissue alone 
or seeded onto a 
support matrix 




Ceramic based Used alone or in 
combination with 
other materials 
Calcium phosphate cement 
Calcium sulfate  
Calcium hydroxyapatite (HAp) 
Tri-calcium phosphate (TCP) 
Bioactive glass 
Polymer based Degradable and 
nondegradable 
polymers 
Open porosity polylactic acid polymer 
(OPLA) 






In this study, cell-based bone graft substitutes were investigated focusing on the 
potential of stem cells to improve bone healing. 
2.3 Stem cells 
Stem cells are cells of different origins with a high self-renewal capacity 10 and can be 
divided into two groups: embryonic stem cells (ESCs) and non-embryonic adult or 
somatic stem cells.11, 12 
ESCs are pluripotent cells and can be isolated from the inner cell mass of a 
blastocyst. This leads to the destruction of the blastocyst and causes ethical issues.13 
Adult stem cells are multipotent cells and can be divided into two populations: 
hematopoietic stem cells and mesenchymal stem cells (MSCs).11 Such MSCs can be 
isolated from bone marrow aspirates known as bone marrow stromal stem cells 
(BMSCs). 
Mesenchymal stem cells have a high potential for proliferation and differentiation. 
The activation or suppression of genes allows their differentiation to be actively 
controlled. They can differentiate into different cell types for example osteogenic, 
chondrogenic or adipogenic cells. It has been shown that MSCs are involved in 
intramembranous ossification and can differentiate into osteoblasts.14 Therefore, 
mesenchymal stem cells are regarded as a source of osteogenic cells, but their use 
in the clinic has not yet been established. In part, this can be explained by the fact 
that mesenchymal stem cells represent a very inhomogeneous cell population, which 
can, in turn, lead to varying efficacy as osteogenic cells. 
Recent in vitro studies demonstrated that the osteogenic differentiation of human 
bone marrow mesenchymal stem cells depends on the ratio of two important 
transcription factors: Runx2 and Sox9.15–17 Neither Runx2 nor Sox9 is a specific 
marker for osteogenesis. Runx2 is known as an important transcription factor 
expressed in MSCs for their osteogenic differentiation.18 Sox9 is involved in 
chondrogenic differentiation, but Loebel et al showed that Sox9 also plays a major 
role in the regulation of osteogenesis by interacting with Runx2 by repressing its 
activity. Thus, the Runx2 / Sox9 ratio has been recommended to describe the 
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osteogenicity of human MSCs. This has been proposed as a promising early 
screening method.15, 18 
Smart-FlareTM probes can detect mRNA using nanoparticle probes (Figure 1). The 
probes consist of two different strands attached to gold nanoparticles. One strand is a 
capture oligonucleotide specific for the gene of interest. The other strand is a 
fluorescently labelled short oligonucleotide. When complimentary RNA is present, the 
fluorescently labelled short oligonucleotide leaves the gold nanoparticle and 
fluoresces. These cells can be used afterwards for further investigations or 
therapies.15, 19 Li et al used this method to observe mRNA expression of Runx2 and 
Sox9 in living cells at the individual cell level.15 
Smart-FlareTM probes for Runx2 Cy3 and Sox9 Cy5 were used to prospectively 
identify a more homogenous population of hBMSCs by sorting the isolated cells with 
fluorescence activated cell sorting (FACS). In a second step a mineralization assay 
was used to further investigate the isolated cell population. A fraction with an 
increased osteogenic differentiation potential and a decreased proliferation rate was 
identified. These sorted, more homogeneous cells showed an improved osteogenic 
potential when compared to unsorted heterogeneous cells in vitro.15 Thus these 





Figure 1: The SmartFlare™ probe's simple mechanism reveals the RNA content of live cells 
while keeping cells alive and intact. SmartFlare™ probes enter the cell using the cells's own 
endocytosis process. The probes circulate within the cell and bind to the complementary RNA 
sequence. This binding event releases a fluorophore, illuminating the cells for detection. Over time, the 
probe exits the cell, leaving the cell unchanged and free for downstream analyses. (Figure and text 
kindly provided by Merck KGaA Darmstadt) 
2.4 Hypothesis 
Within the scope of this "proof of concept" study the goal was to confirm these in vitro 
results in vivo. The sorted and thus more homogeneous cell population was 
compared with the unsorted cell population. The hypothesis was that hBMSCs sorted 
based on their Runx2 to Sox9 ratio lead to more newly formed bone within the first 
four weeks after defect creation surgery than unsorted cells in calvarial defects in 
nude rats.  
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3 Materials and methods 
3.1 Study Design 
All procedures were carried out in an AAALAC (Association for Assessment and 
Accreditation of Laboratory Animal Care) accredited and GLP (Good Laboratory 
Practice) certified facility according to the Swiss Laws of animal welfare. The animal 
experiments were approved by the Animal Welfare Commission of the official 
veterinary authorities (Authorization Number GR 33_2016). 
Twelve female RNU (Crl:NIH-Foxn1rnu) nude rats (13 to 17 weeks-old), purchased 
from Charles River Laboratories, Germany, were enrolled in this study. Each 
received two five millimeter calvarial bone defects. The calvarial defect serves as a 
model for intramembranous bone formation.20, 21 Since the isolated cells are more 
osteoblastic in nature, this intramembranous calvarial model was used. Five mm 
defects are reported to be subcritical 20 or critical defects. 22, 23 
RNU nude rats were chosen in order to avoid an immune reaction to the human 
mesenchymal stem cells (hBMSCs) which were used in this study. They are athymic 
and T-cell deficient and show depleted cell populations in thymus-dependent areas of 
peripheral lymphoid organs.24 
The defects were systematically randomized between three groups according to 
Table 2. They were filled with a collagen membrane which contained either sorted 
hBMSCs based on the ratio of the two transcription factors Runx2 and Sox9 (group 
A), unsorted human mesenchymal stem cells (group B) or, as a control, the collagen 
membrane contained no cells (group C). The collagen membrane was a collagen 




Table 2: Groups 
Group Description 
A Cells sorted on their Runx2/Sox9 ratio seeded on collagen membrane 
B Unsorted cells seeded on collagen membrane 
C Collagen membrane only 
 
The primary goal of this study was to assess the bone healing. Micro computed 
tomography (CT) and histology was used. The rats were scanned in a micro CT 
postoperatively, two weeks after surgery and after euthanasia to follow the progress 
of healing. Bone volume and density at each time point as well as bone evolution 
over time was evaluated (see Figure 2).  
After euthanasia a histological examination for bone formation and inflammation with 
microscopic evaluation and epifluoroscopic analysis followed. The fluorochrome 
Xylenol Orange was injected subcutaneously three weeks after the defect surgery to 
visualize bone formation and bone remodeling at this time point. The investigators 




Figure 2: Timeline 
3.2 Animals 
 Inclusion criteria and preoperative care 
Specific pathogen free (SPF) female RNU (Crl:NIH-Foxn1rnu) nude rats were 
purchased from Charles River Laboratories, Germany. They were acclimatized for 
five to nine weeks before the start of the study. The inclusion criteria were defined as 
an age of twelve to 18 weeks with a weight of 150 to 250 grams before the surgery. 
All rats had to have a health certificate from the breeder and to be judged clinically 
healthy based on a preanesthetic clinical examination by a veterinarian.  
To prevent eye problems due to the missing eyelashes of nude rats, the eyes were 
cleaned two times a week with sterile Ringer's solution (B. Braun Melsungen AG, 
Germany) and sterile swabs (IVF Hartmann AG, Switzerland). 
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 Housing and feeding 
Up to four rats per cage were group housed in individually ventilated cages (IVC, 
Type 2000 Rat Cage, Allentown Inc, United States) with an area of 2000 cm2 and a 
height of 26 cm with a 12:12 hours light:dark cycle and bedded on laboratory wood 
bedding (ABEDD Vertriebs GmbH, Austria). All procedures with the animals were 
performed in a laminar flow work station (Phantom Animal Transfer Station, 
Allentown Inc, United States). Room temperature was maintained at 22 ± 2 °C with a 
relative humidity of 40-60 %. In the background, a radio (<80 dB) ran in order to 
accustomize the animals to noise and to prevent stress due to a suddenly rising 
noise level (e.g. feeding, cage changes). 
As an enrichment material, the rats were given paper, a cardboard house and wood 
for gnawing on. 
The rats were fed ad libitum a commercial pelleted diet food (KLIBA NAFAG, 
PROVIMI KLIBA AG, Switzerland: "mouse and rat maintenance" Extrudate 15 mm 
round). They were offered water ad libitum at all times. 
In the week before the operation the rats were offered a nutritional gel (MediGel® 
Sucralose, ClearH2O, Bio Services, The Netherlands) in the cage so that they could 
get used to this nutritional gel which served as a carrier gel after surgery for 
administration of carprofen medications. 
 Health monitoring 
Samples of three different locations (body swab, oral swab, fecal pellets; all samples 
from the same location from all animals were pooled) for a Rat Surveillance PRIA 
(PCR Rodent Infectious Agent) Test were collected two weeks before surgery and 
just before euthanasia to gain an overview of the health status and to identify viral, 
bacterial, fungal and parasitic agents in the animals. This special health monitoring 
test is based on PCR assays and is available for different pathogens (for a list of all 
agents see Attachments).25 The samples were analyzed by Charles River Research 
Animal Diagnostic Services, Wilmington, USA. 
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3.3 Cells and membrane 
A Collagen Type I Cell Carrier, Ø seven mm from Viscofan BioEngineering, 
Weinheim, Germany was used in the study. These membranes are 20 µm thin based 
on fibrillar, bovine collagen I and chemically non-crosslinked. They were trimmed to 
five mm diameter using a sterile biopsy punch (kai medical, kai Europe GmbH, 
Solingen, Germany). 
Bone marrow was harvested from the femoral head from a 91 year old male human 
(Ethical approval: Freiburg, EK-326/08) and diluted 1:4 with phosphate buffered 
saline (PBS, Sigma-Aldrich Chemie GmbH, Switzerland). The mixture was carefully 
layered on a Ficoll cushion (Histopaque-1077, Sigma-Aldrich Chemie GmbH, 
Switzerland), and centrifuged at 800× g for 20 minutes. The mononuclear cells were 
collected from the liquid interface. To exclude red blood cells a gated cell count was 
performed using a cell Scepter 2.0 Automated Cell Counter (Millipore, Germany). 
Isolated mononuclear cells were seeded at a density of 50,000 cells/cm2 in cell 
culture flasks, and cultured in α -modified essential medium (α -MEM; GIBCO, 
Switzerland), 10% fetal bovine serum (Sera Plus, PAN-Biotec, Germany), 1% 
penicillin and streptomycin (GIBCO, Switzerland), and 5 ng/ml recombinant human 
basic fibroblast growth factor (bFGF, Fitzgerald Industries International, USA). 
Nonadherent hematopoietic cells were removed after four days. Cells were incubated 
at 37 °C and 5% CO2 and the medium was refreshed every second day. Cell surface 
marker profiling was performed at passage one according to previous protocols.26 
The potency of the expanded attached cells to differentiate towards chondrogenic, 
osteogenic and adipogenic lineages was confirmed.15 
Passaged hBMSCs were cultured in a growth medium which contains α -modified 
essential medium (α -MEM; GIBCO, Switzerland), 10% fetal bovine serum (Sera 
Plus, PAN-Biotec, Germany), 5 ng/ml recombinant human basic fibroblast growth 
factor (bFGF) and 1% penicillin and streptomycin (GIBCO, Switzerland) for one week 
to achieve the desired number of cells with an initial seeding density of about 
3000/cm2. Normal growth medium allows proliferation of the cells but no 
differentiation.  
hBMSC foreseen for group A were induced with osteogenic induction medium which 
contains Dulbecco´s modified Eagle’s medium low glucose (DMEM; GIBCO, 
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Switzerland), 10% fetal bovine serum (Sera Plus, PAN-Biotec, Germany), 1% 
penicillin and streptomycin (GIBCO, Switzerland), 50 μ g/ml ascorbic acid, 10 nM 
dexamethasone and 5 mM β -glycerol phosphate (Sigma-Aldrich, Switzerland) for 
one week. Osteogenic induction medium allows differentiation of the cells. These 
cells were sorted using flow cytometry (BD Aria III, BD Biosciences, Switzerland) 
based on their Runx2/Sox9 ratio as described by Li et al 15. Therefore, SmartFlare™ 
probes for Runx2 and Sox9 were added to the medium and incubated at 37°C and 
5% CO2 overnight. To detach the cells after 16 hours 0.05% Trypsin-EDTA (GIBCO, 
Switzerland) was used. The cells were centrifuged at 2000 rpm for 10 min. and the 
cell pellet was resuspended in growth medium afterwards. Finally the cells were 
analyzed based on their fluorescence intensity by FACS and sorted into four 
populations. The population with a low Sox9 and a low Runx2 fluorescence intensity 
(P1 population as characterized by Li et al 15) was selected to be used in this study. 
This population showed in vitro the highest osteogenic differentiation potential and 
lowest proliferation rate. This corresponds most closely to the properties of 
osteoblasts.15 
hBMSCs foreseen for group B (no sorting) were cultured in growth medium for two 
weeks. These cells were not induced with osteogenic induction medium. 
Two days prior to surgery the cells of all groups were seeded on the membrane to 
allow cell attachment and were cultured in growth medium. Before seeding, 
membranes were first attached on the plate (96 well plate) overnight according to the 
manufacturer's instructions. The cells were seeded on the upper side of the 
membrane and they were implanted in the animal so that the cells were on the top. 
Cell number was constant at 375,000 per membrane. The exact number was 
determined at the time of seeding. 
Membranes for group C were also placed in 96 well plates with the same growth 
medium two days prior to surgery. 
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3.4 Surgical Intervention 
 Anesthesia & Analgesia protocol 
The surgery was performed under general anesthesia. Inhalation agents were 
preferred for this study because of their controllability. Sevoflurane (Sevoflurane 
Baxter®, Baxter AG, Switzerland) was used in oxygen in a non-rebreathing 
anesthesia system. The animals were placed in an induction box with oxygen (1l/min) 
and 5-6% sevoflurane. 
When the animal was recumbent and the righting reflex was absent the animal was 
taken out of box and the animals head was placed in the face mask. The vaporizer 
setting was reduced to 2-3% sevoflurane and the oxygen flow to 0.6-1.0 l/min. Eye 
lube was applied in both eyes (Vitamin A Blache Augensalbe, Bausch und Lomb 
Swiss AG, Switzerland) to prevent drying of the cornea. 
During the preparation and surgery, the respiratory rate was monitored by an 
experienced anesthetist and the animals were placed on a heating pad to maintain 
core temperature. The temperature was measured rectally before surgery and after 
CT. 
Preoperative analgesia: Preoperatively, buprenorphine (Bupac®, Streuli Pharma AG, 
Switzerland, 0.01 mg/kg, subcutaneously) and carprofen (Norocarp®, ufamed AG, 
Switzerland, 5 mg/kg, subcutaneously) were given to the rats for pain management.  
Intraoperative analgesia: Ropivacaine 2 mg/ml (ROPIVACAIN Fresenius, Fresenius 
Kabi, Switzerland, 3 mg/kg) was dropped onto the periosteum after cutting the skin. 
Postoperative analgesia: The rats were injected with buprenorphine (Bupac®, Streuli 
Pharma AG, Switzerland, 0.01 mg/kg, subcutaneously) 4-6 h and 9-11 h after surgery 
and the next morning. Additionally, the animals received carprofen (5 mg/kg) in a 
nutritional gel (MediGel® CPF, ClearH2O, Bio Services, The Netherlands) oral for the 
first three days post-surgery.  
The animals received two Milliliters of warm lactated Ringer's solution (B. Braun 
Medical AG, Switzerland) subcutaneously at the end of surgery to prevent 
dehydration of the animals. 
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All substances, their manufacturers, dose rates and routes and intervals of 
administration are listed in the table below. 
Table 3: Used drugs during study 
Purpose Substance 
Registered trade name 
/ Swiss manufacturer / 
Swissmedic no. 






Sevoflurane Baxter® / 
Baxter AG / 57671 
2-3% Sevoflurane in 




Bupac® / Streuli Pharma 
AG / 63081 
0.01 mg/kg s.c. 
Carprofen 
Norocarp® / ufamed AG / 
60459 





/ Fresenius Kabi AG / 
61877 
3 mg/kg s.c. 
Post-operative 
analgesia 
Buprenorphine as above 
0.01 mg/kg s.c. 
4-6 h and 9-11 h 
after surgery and the 
next morning  
Carprofen 
MediGel® CPF / Clear 
H2O  
5 mg/kg oral for 3 
days 
 
 Surgical procedure 
The animal was placed in sternal recumbency, the head was clipped and aseptically 
prepared with diluted Betadine solution (Mundipharma Medical Company, 
Switzerland) followed by a rinse with sterile Ringer's solution (B. Braun Melsungen 
AG, Germany). The rats were draped with sterile incise-drapes (DYNJSD1021, 
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Medline, USA) on a sterile covered table (8371CEB, Medline, USA). A straight skin 
incision down to periosteum was made over the scalp sagittaly from the nasal bone 
to the occipital bone (Figure 3). 0.3 ml of Ropivacain (2 mg/ml, Fresenius Kabi AG, 
Switzerland) was dripped on the periosteum. After three minutes waiting period the 
periosteum was sharply divided in the midline and then gently pushed laterally.  
In the area of the parietal bones, two evenly distributed five mm diameter craniotomy 
defects were prepared, one on each side of the sagittal suture (Figure 4), with a five 
mm Diamond-Trephine (JMP Dental GmbH, Germany, Art. No. DD229040) and a 
dental handpiece under constant irrigation with sterile Ringer's solution (B. Braun 
Melsungen AG, Germany) to prevent overheating. Initially the hole was pre-drilled 
with the trephine only. Then a custom-made metal ring was screwed on the trephine 
to limit the drill depth to less than one millimeter (Figure 5). A preliminary study on 
skulls of rat cadavers revealed a calvarian bone thickness of around 0.5 mm. The 
bone was not entirely penetrated by the trephine. The trephine was only used 
gradually until the bone was perforated at one point and the dura mater became 
visible. To assure the preservation of the dura mater a small blunt periosteal elevator 
was then used to remove the bone from the defect (Figure 6). Care was taken to 
avoid injury to the dura mater. Any damage to the dura mater was recorded on the 
surgery report. 
Subsequently, the surgical area was thoroughly flushed with sterile Ringer's solution 
(B. Braun Melsungen AG, Germany) to remove bone debris. The two defects were 
filled with the materials to be tested according to Table 10 (see Attachments). The 
membranes were sized to fit exactly into the defects and were positioned on the dura 
mater but not secured. They were placed in a way that the seeded cells were located 
on the upper side of the membrane. Wound closure was performed in a two-layer 
technique: fascia single interrupted sutures (Vicryl rapid 5-0, Ethicon, Johnson & 
Johnson Medical, Switzerland) and skin in a continuous suture pattern 
intracutaneously (Vicryl rapid 5-0, Ethicon, Johnson & Johnson Medical, 
Switzerland). 
The preparation of the animal and the surgery were carried out under a laminar air 






Figure 3: Position of skin incision (red line); 
rostral shown at left side, caudal at right side. 
 Figure 4: Position of the two defects in the 
calvaria; rostral shown at left side, caudal at 
right side. 
 
      
 
      
Figure 5: A: Five mm Diamond-Trephine (JMP Dental GmbH, Germany, Art. No. DD229040), 









Figure 6: Creation of the defect shown on a cadaver, rostral is always left: Skin incision (A). 
Sharp incision of the periosteum in the midline and gentle removal to laterally (B). Pre-drilling of the 
defect with trephine only (C, D). Final drilling with a metal ring screwed on for depth control (E). 
Removal of the bone from the defect with a small blunt periosteal elevator (F). Defects with the 
exposed dura mater and brain shimmering through (G). Placement of the membrane into the defect 








 Postoperative care 
After surgery, the rats were directly transferred into the CT holder (see 3.6.3 Micro 
computed tomography), imaged, then taken out of the CT holder and placed in a 
recovery cage. 
During the recovery phase, all animal stayed under the supervision of a veterinarian 
until fully awake and return of righting reflex. To prevent hypothermia a heating pad 
was placed under the cage and infrared light above the cage. 
3.5 Animal welfare assessment 
To guarantee an objective assessment of the postoperative animal welfare a 
predefined score sheet was used (Figure 7). The rats were scored twice a day for the 
first 3 days postoperatively, and daily thereafter for the first 7 days after surgery. 
Afterwards they were scored weekly. The scoring was performed by veterinarians 
and qualified animal caregivers. 
This scoring was based on behavior, appearance of skin, fur and eyes, hang of the 
head, breathing, wound healing, weight loss and feces. It defined abruption criteria 
and actions to be taken depending on the achieved score (Figure 8): A veterinarian 
had to examine each animal that reached a score of more than three. He could adapt 
the treatment plan (for example he could administer additional analgesia) and had to 
decide if the scoring frequency had to be intensified. 
Abruption criteria were defined as a score higher or equal to six for three days or a 
single score of equal or more than ten to avoid a high burden of the animal. Further 
any incident, which influence the study results (for example infections or diseases 





- quiet and attentive 0 
- huddled/inactive OR hyperactive 2 
- apathetic= no reaction to stimulus 4 
Appearance (fur, eyes, skin) 
 
- normal 0 
- little dirty, sticky, scrubby fur 1 
- very dirty, sticky, loss of fur 3 
Head position 
 
- normal, head straight 0 
- partial head tilt  1 
- constant head tilt 2 
- head tilt, neurological symptoms 3 
Breathing 
 
- normal 0 
- increased frequency 2 
- very intensive 3 
Wound healing 
 
- normal 0 
- signs of inflammation (swelling, reddening, temperature ↑) 1 
- signs of infection (secretion, + signs of inflammation ↑) 3 
Surgery weight 0 
- loss of 1 - 10% to surgery weight 1 
- loss of 11 - 20% to surgery weight 3 
- loss of > 20% to surgery weight 4 
Feces/urine 
 
- normal  0 








0 to 3 no to moderate disturbance/suffering 
4 to 9 moderate pain/suffering → increase observation interval, drugs 
≥10 severe pain/suffering → consider abruption criteria → euthanasia 
Group housing: if score ≠ 0 → examine individual rat 
if score more than 3 days ≥6 → consider abruption criteria → euthanasia 
Figure 8: Measures to be taken depending on score 
3.6 In vivo analysis 
 Body weight 
The body weight was measured at surgery, three and seven days after surgery, 
weekly thereafter and at euthanasia. 
 White blood cell count 
Before surgery, at two weeks before the CT scan and before euthanasia 100-200μl 
blood from the tail vein was collected in EDTA tubes (Microvette®, SARSTEDT AG & 
Co., Germany) for determination of the white blood cell count (VetABC, Scil animal 
care company GmbH, Germany). 
 Micro computed tomography 
Micro computed tomography scans (VivaCT40, Scanco Medical AG, Switzerland) of 
the rat skull were performed while immobilizing the animal in a custom-made holder 
(Figure 9) under Sevoflurane anesthesia as described in 3.4.1. The animals were 
scanned directly postoperatively, two weeks after surgery and after euthanasia (four 
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weeks after surgery). Under the laminar air flow hood (Phantom Animal Transfer 
Station, Allentown Inc, United States), the animals were placed in sternal 
recumbency and the holder was closed at its best to protect the animal from the 
scanners environment (Figure 10). The holder had a built-in heating system to avoid 
heat loss of the animal during the scanning which lasted approximately 30 min. The 
region of interest was scanned using 70 kVp, 114 µA, 200 ms integration time and a 
38.9 mm field of view reconstructed across an image matrix size of 2048 x 2048, 
resulting in an isotropic voxel size of 19 µm. The acquired scan data of the three time 
points were registered to each other using IPL (Image Processing Language) 
provided by the manufacturer. Bone volume at each time point as well as bone 
evolution over time was evaluated within a cylindrical volume of interest (VOI; d=263 
pixels) which was fitted into the defects created during surgery. The identical VOI 
was then applied to the later time points. Bone volume, present in the VOI after 
surgery, was subtracted from all time points. 
 
   
Figure 9: Custom-made holder: showing the extension for the animal’s head and its fixation in the 
anesthetic mask. A: without rat from above, B: with rat in place from above, C: with rat in place lateral 
  
Figure 10: Closed custom-made holder: A: without rat (heating system not shown), B: with rat in 
place 




 Fluorochrome labeling 
The fluorochrome Xylenol Orange was injected three weeks post-surgery (90 mg/kg 
BW, subcutaneously) to visualize bone formation and bone remodeling in histological 
sections. Xylenol Orange is incorporated in newly formed calcified tissues that allow 
showing which bone calcified at the time of administration of the dye.27 
3.7 Euthanasia, sample harvest and post mortem evaluations 
 Euthanasia 
After putting the animals in Sevoflurane anesthesia four weeks post operatively, the 
animals blood was withdrawn from the tail vein as described in 3.6.2 and samples 
were collected for PRIA-Testing as described in 3.2.3. Thereafter the animals were 
euthanized by intracardial puncture and administration of an overdose of 
Pentobarbital (200 mg/ml; 0.6 ml Esconarkon® (Streuli Pharma AG, Switzerland) 
mixed with 0.3 ml sodium solution (NaCl 0,9 %, B. Braun Melsungen AG, Germany). 
The animals were always separated from other animals before euthanasia and 
euthanasia was carried out in a separate room by a veterinarian. 
For all animals euthanized, a macroscopic examination of the external body surface, 
all orifices and surgery sites was conducted. After euthanasia, animals were weighed 
and the head was scanned with CT.  
 Sample harvest 
The calvaria without soft tissues with the two defects were cut from the skull using an 
oscillating saw. The right caudal corner was cut off to mark the bone fragment for 







Figure 11: Position and marking of bone 
sample to be cut from skull after 
euthanasia. 
 Figure 12: Harvested calvaria 
 
 Histology 
3.7.3.1 Histological processing 
The samples were fixed in 70% ethanol (Alcosuisse, Switzerland) for four weeks, with 
at least one change to fresh solution per week, before continuing with the processing. 
During the fixation time, contact radiographs of the samples were made using a 
Faxitron X-Ray Cabinet (#43855A, Faxitron X-Ray Corporation, Schweizer AG, 
Switzerland) applying a voltage of 20kV, no filter and an exposure time of 40 
seconds, using a high-resolution film (D4 Structurix, AGFA, Belgium) and developed 
(AGFA Structurix NDT-M eco Developer, AGFA, Belgium). The samples were then 
dehydrated through an ascending series of ethanol (70%, 96%, and 100%; 
Alcosuisse, Switzerland) with two changes for each step, transferred to xylene 
(Brenntag Schweizerhall AG, #10934-550, Switzerland) for four days and then finally 
to methyl methacrylate (Sigma-Aldrich Chemie GmbH, #5590-9, Switzerland) for 
embedding. First the samples were put into MMA I solution for three days, afterwards 
into MMA II solution for three days and stored refrigerated (4°C). For additional five 
days, the samples were applied to MMA III solution with a softener, dibutyl-phthalate 





(4°C). To prevent overheating during polymerization the samples were further cooled 
in a water bath for seven days at room temperature. After the polymerization was 
completed they were hardened in an oven at 40 – 60°C overnight. 
The polymerized samples (Figure 13) were trimmed using a butcher saw so that they 
could be glued (cyanoacrylate adhesive, Cyanolit, Panacol-Elosol GmbH, Germany) 
onto holders to fit into annular blade saws (Leica SP 1600 saw microtome, Leica AG, 
Biosystems AG, Switzerland) and sectioned. Serial sections, cut in a coronal plane, 
of around 500 µm were made around the center of each sample.  
 
Figure 13: Fixed sample embedded in MMA (ready for cutting) 
Before proceeding any further, contact radiographs were made, this time not of the 
full thickness samples but of the sections. Two sections of each defect side, which 






Figure 14: Contact radiograph of the un-glued, not-ground thick-sections displaying the 
process of choosing the sections for further proceeding. In this case sections # 5 and 6 (yellow 
circles) were chosen for the right defect, sections # 12 and 13 for the left defect (blue circles). (The 
number in the upper left corner gives the resin-block # [here 27215 corresponds to animal # 1]. The 
numbers at the left side give the number of the individual slide [here 1, 6, 11, 16 up to a total of n= 
20]). 
The sections were glued onto opaque Plexiglas slides (75x25x2mm, Semadeni AG, 
Switzerland), ground and polished (Exakt Micro Grinding System, Exakt 
Apparatebau, Germany), using varying roughnesses of grinding papers (P1200, 
P2400 and P4000, Struers GmbH, Switzerland), to obtain a final thickness of around 
125 µm.  
One of the sections of each defect side remained unstained for the observation of the 
fluorochrome labels. For the staining, the sections were etched using 1% formic acid 
(Fluka #06460, Sigma-Aldrich, Switzerland) for 30 seconds. Then the slides were 
rinsed with tap water for five minutes before they were stained with a 15% Giemsa 
solution (Fluka Analytical #48900, Sigma-Aldrich, Switzerland) heated to 55°C for 45 
minutes, rinsed for 5 minutes and counterstained with a 1% Eosin working solution 
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for 2 minutes, containing 1% Eosin stock solution (Eosin Yellowish, Fluka #45240, 
Sigma-Aldrich, Switzerland) and acetic acid (Glacial Acetic Acid, Fluka #45731, 
Sigma-Aldrich, Switzerland). Finally, the slides were differentiated for two seconds 
with 70% ethanol, then five seconds in 96% ethanol and dehydrated two times with 
absolute ethanol for two minutes each. 
3.7.3.2 Microscopic Evaluation 
The microscopic evaluation was performed blinded by a veterinarian pathologist (FTA 
Pathology and Toxicopathology, Germany) and by the author using a discussion 
microscope (U-DO3, Olympus Corporation, Japan). With the use of the GE-stained 
slides, the defect healing was semi-quantitatively analyzed applying a grading 
scheme (grade 1= minimal, grade 2= slight, grade 3= moderate, grade 4= marked, 
grade 5= massive, Table 4). Special attention was given to regenerative and 
reparative tissue changes, including newly formed calvarial bone (relative 
amounts/percentage of defect closure, thickness, vascularization, necrosis), changes 
at the soft tissue (e.g. fibrous/fat/muscle tissue), and at the collagen membrane 
(remnants, degeneration) in the defect. Furthermore, other changes like hemorrhage, 
hemosiderin deposition, inflammation (lymphocytic/granulocytic/granulomatous), 
metal remnants or damage of adjacent tissue structures were analyzed, as well as 
the defect closure over the length of the defect with newly formed bone in %. A defect 
closure of estimated 1-20 % corresponded to a grade 1, up to 40 % to a grade 2, up 
to 60 % to a grade 3, up to 80 % to a grade 4 and a defect closure of estimated up to 
100 % to a grade 5. 
The metal remnants were only graded with P=present or 0=not present. 
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Table 4: Histological grading 
Grade Grading general Grading defect closure 
1 minimal 1-20 % 
2 slight -40 % 
3 moderate -60 % 
4 marked -80 % 
5 massive -100% 
 
3.7.3.3 Epifluoroscopic analysis 
To compare bone formation over time, a semi-quantitative analysis of fluorochrome 
(Xylenol Orange) labelled mineralization lines was performed blinded on unstained 
thick sections using a fluorescence microscope (AxioPlan2 Microscope, Zeiss, 
Oberkochen, Germany) applying a grading scheme (grade 1= minimal, grade 2= 
slight, grade 3= moderate, grade 4= marked, grade 5= massive). 
3.8 Statistical evaluation 
The data was checked for normal distribution by exploring qq-plots as well as using 
the Shapiro-Wilk normality test. Since the data was not normally distributed, a non-
parametric ANOVA in order to determine the influence of the treatment (organized 
into groups A, B, C) was used thereafter. Such an analysis was performed for the CT 
bone volume at both times (2 and 4 weeks), the inferred bone growth as well as for 
the histological data (Defect Closure, Thickness, Vascularization). The bone growth 
was calculated as the change in bone volume normalized by the time between the 
two measurements. In addition, another non-parametric ANOVA was performed in 
order to determine whether or not the white blood cell (WBC) decreased over time. 
The associated test for all non-parametric ANOVA's was the Kruskal-Wallis Rank 
sum test, and the significance level was fixed at 0.05. The analysis was done using 




4.1 Inclusion criteria, excluded animals and group size 
All twelve animals enrolled into the study fulfilled the inclusion criteria at the 
beginning of the study as described in 3.2.1 with an age of minimum 13 weeks (eight 
animals) and a maximum of 17 weeks (one animal). This results in a mean age of 
13.4 weeks with a standard deviation of 1.3.  
All rats were considered healthy based on their health certificate (Charles River 
EEW29863) and the preanesthetic clinical examination. In total three out of the 
twelve rats had to be excluded. The animal numbers and reasons for exclusion are 
summarized in Table 5. 
Animal # 0 was replaced immediately, since the membranes with the cells were not 
yet placed in the animal as it passed away. Animal # 10 died in anesthesia during CT 
when the membranes with cells were already located in the animal. Because no 
additional sorted cells were available, we could only replace the defect with group C. 
The other defect in this animal was left empty. Animal # 2 in which there was a brain 
injury during surgery could not be replaced because no more animals were available. 






Reason for exclusion Replacement 
0 NA / NA 
died before surgery during 
anesthesia - stopped breathing 
Both groups 
(animal # 1) 
2 C / B 
surgery: brain injury and 
prolapse – euthanasia 
No 
10 C / A 
died during CT anesthesia post- 
OP - stopped breathing 
Only group C 




Therefore, a total of nine animals were included in the analysis (Table 6). Thus, six 
defects each in groups A and B and five defects in group C were included (Table 7). 
Table 6: Animals included in analysis 
Animal # Left defect filled with group Right defect filled with group 
1 B C 
3 C B 
4 A B 
5 A C 
6 B A 
7 C A 
8 A B 
9 B A 
11 C Empty 
 
Table 7: Number of defects per group included in analysis 
Group Description 
Number of defects 
included in analysis 
A 
Cells sorted on their Runx2/Sox9 ratio seeded 
on collagen membrane 
6 
B Unsorted cells seeded on collagen membrane 6 




4.2 Injuries to the dura mater intraoperatively 
Out of the 22 drilled defects the dura mater was injured in four defects although using 
the drilling technic as described in 3.4.2 Surgical procedure. As shown in Table 8 a 
small hole up to 1 Millimeter was generated in the dura mater within three defects 
(one in group B, two in group C). In animal # 2, the dura and brain were damaged 
because of a too deep drilling. This animal was euthanized and excluded. In two 
defects, we could observe a subdural hematoma without a dura mater injury.  
Table 8: Dura mater injuries intraoperatively 
 




yes no comment yes no comment 
1 (B/C) x    x small hole, approx. 1mm 
2 (C/B) x    x brain injury and prolapse 
3 (C/B) x   x   
4 (A/B) x   x   
5 (A/C) x   x   
6 (B/A) x   x   
7 (C/A) x   x  hematoma subdural 
8 (A/B) x    x small hole, no prolapse 
9 (B/A) x   x  hematoma subdural 
10 (C/A) x   x   




4.3 Health monitoring 
The results of the rat Surveillance PRIA (PCR Rodent Infectious Agent) analyzed by 
Charles River Research Animal Diagnostic Services, USA were all negative two 
weeks before surgery and at the time of euthanasia. 
4.4 Weights 
The animals included in the study had a weight of 200 g ± 20 g. Seven out of nine 
animals lost weight after the surgery. The maximum weight loss was 9% (mean of 
2% with a standard deviation of 3.2) in the first week and up to 7% (mean of 2%, 
standard deviation 2.5) in the second week compared with the body weight at 
surgery. All animals reached their pre-OP weight or even gained weight after three 
weeks after surgery. From this time on all animals could keep their post op weight or 
even weighed more than before the surgery (Figure 15). 
 
Figure 15: Change in body weights in % compared to the preoperative weight 
4.5 White blood cell count 
The white blood cell count, as a systemic measure able to indicate acute 
inflammation, was determined for each animal at time of surgery, after two weeks 









































physiological healthy range (2-7 Tsd. leukocytes/µl) for RNU nude rats as described 
by Bani Ismail et al. 28. The WBC levels significantly decreased over time (chi=5.85, 
p=0.05). 
 
Figure 16: White blood cell count (Tsd./µl) 
4.6 Animal welfare 
The following scores were documented: During the first three days after surgery a 
score of zero to three was observed in the animals, with a score of three being 
observed only in two animals on the evening of the surgery due to huddled/inactive 
(two points) and partial head tilt (one point). By day six the value for the score was 
between zero and one. From week three on all animals had a score of zero. The 
highest score which we could observe across all groups at all time points was three. 
4.7 Necropsy 
During necropsy abnormalities were found in two rats. In animal # 7 the left defect 
was higher and the right defect was deeper and darker than the surrounding tissue. 
































   
Animal # 1 Animal # 3 Animal # 4 
   
Animal # 5 Animal # 6 Animal # 7 
   
Animal # 8 Animal # 9 Animal # 11 
Figure 17: Overview calvaria after dissection, orientation: top always rostral, left always left; Note in 
animal # 7 the left defect was higher (open black arrow head) and the right defect was deeper and 
darker than the surrounding tissue (open white arrow head). Animal # 9 showed red spots on both 

















4.8 Micro computed tomography analysis 
To monitor the healing process and new bone formation over time, CT scans were 
performed at two and four weeks post op (euthanasia) as indicated in 3.6.3. Healing 
was assessed by comparison of these scans with images taken directly post-
operatively. A representative 3D reconstruction of microCT images is given in Figure 
18 (for an overview of all individual defects see Attachments). Only the bone of the 
cranium is shown in the images. New bone formation in between time points is 




Figure 18: Representative 3D reconstruction of the cranium, animal # 3: A: post op, B: after two 
weeks, C: after four weeks. New bone formation in between time points is highlighted in orange. 
Rostral: always shown at top of the picture. 
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None of the animals could heal the defect in the observation period. Defects of group 
A and B showed similar healing outcomes after two (mean 0.486 and 0.488 mm3; 
SD=0.197 and 0.192) as well as after four weeks (mean 1.798 and 1.860 mm3; 
SD=0.693 and 0.611) based on the bone volume. Group C showed an increased 
bone volume in the defect compared to group A and B both after two (mean 0.810 
mm3; SD=0.458) and four weeks (mean 2.362 mm3; SD=1.043). Nevertheless, the 
CT data revealed no significant influence of the group (=treatment) factor (bone 
volume after two weeks: chi=1.12, p=0.57; bone volume after four weeks: chi=1.35, 
p=0.51; inferred bone growth: chi=1.06, p=0.59). However, the bone volume 
measured with CT significantly increased over time (chi=21.144, p<0.05). 
The three defects with an injury of the dura mater (Table 8) showed a decreased 
healing after two weeks post OP compared to the other defects of their group. After 
four weeks this decreased healing was still present in two defects (animal # 1 right 
defect, # 8 right defect). The left defect of animal # 11 has caught up between two 




Figure 19: Bone volume per group at two and four weeks 




















Figure 20: Bone volume per defect. Defects with dura mater injury are orange bordered. L (left) and 
R (right) marks defect side, # = animal # 
Additionally to the three groups, one defect of animal # 11 (right side) was left empty 
(no membrane and no cells). This defect had formed less new bone after two and 
four weeks than all defects of group A, B and C. After two weeks it had a new formed 
bone volume of 0.172 mm3 compared to 0.348 mm3 (group A), 0.210 mm3 (group B) 
and 0.286 mm3 (group C) as the lowest values in these groups. The same ratio was 
observed after four weeks: the empty defect had formed 0.656 mm3 new bone 
compared to 1.179 mm3 (group A), 0.824 mm3 (group B) and 0.752 mm3 (group C) as 
the lowest values in these groups. However, for these values, it must be mentioned 
that the lowest values of groups B and C belong to defects with an injury of the dura 
mater. The values of the defects without dura mater injury are higher as shown in 
Figure 20. 
4.9 Histology 
Generally, the mean defect closure by formation of new calvarial bone after four 
weeks was of moderate to high grade. So, defects treated with membrane only had 
the highest defect closure (group C: mean grade 4.0) compared to defects treated 
with membrane + unsorted hBMSC (group B: mean grade 3.2), membrane + sorted 
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individual values in each group (intra-group variation) ranged from grade 1 at the 
lower end, up to grade 5 at the higher end and therefore exhibited a pronounced 
standard deviation (membrane only [group C]: SD= 1,6; membrane + unsorted 
hBMSC [group B]: SD= 1.5, membrane + sorted hBMSC [group A]: SD: 1.5). 
Table 9: Defect closure, *: grade 1: 0-20%, grade 2: 21-40%, grade 3: 41-60%, grade 4: 61-80%, 








mean defect closure by new 
bone, 
[graded 1-5] * 
3.2 3.2 4.6 
standard deviation 
[SD] 
1.5 1.5 1.6 
 
Microphotographs of the defects of group A are shown in Figure 21, of group B in 
Figure 22 and of group C in Figure 23. 
No cartilage tissue could be found in any defect of any group.  
Thickness of the new calvarial bone was relatively low and generally not reaching the 
original levels (mean grades: 2.0 – 2.4) with the lowest mean grade in group A (2.0) 
and the highest mean grade in group C (2.4). All grades between 1 and 3 were found 
in each group. No defect had reached a thickness of a grade 4 or 5. 
Vascularization was low to moderate (mean grade 1.8 – 2.4). The highest mean 
grade was again observed in group C (2.4) whereas the lowest mean grade was 
found in group B (1.8). The highest grade overall groups was 4 and only found in one 
animal (animal # 6, right defect, group A; Figure 21). All other defects were between 
a grade of 0 and 3 with all grades found in each group. An example of new formed 
blood vessels is shown in Figure 24. 
Osteonecrosis, characterized by small areas of empty osteocytic lacunae, was of low 
severity and occurring at low incidence (group A: mean severity 0.5 [incidence 2/6]; 




Severity of granulomatous inflammation in the soft tissue was low and occurred 
around exogenous material (membrane and suture material) as well as endogenous 
material (hairs) with a mean grade of 0.8 – 1.2 and an incidence of 5/6 (group A and 
B) respectively 4/5 (group C).  
Light pink coloured acellular material (interpreted as membrane remnants) was 
visible in seven out of 17 defects with a membrane with an incidence of 2/6 (group A 
and B) or 3/5 (group C) per group. An example of the acellular material is shown in 
Figure 25. All defects with membrane remnants had a grade of 3 for the thickness of 
the new calvarial bone. This grade was only found in one additional defect out of the 
ten defects without light pink coloured acellular material. All other defects had a 
grade of 1 or 2 for the thickness of the new calvarial bone. In addition, all the defects 
with membrane residues had a high grade for vascularization (grade 2 to 4, mean 
grade 3). 
Fluorochrome analysis of Xylenol Orange using epifluorescence microscopy showed 
red-orange marked lines not only in the periphery but also in the center of the defect 
(Figure 26). In the periphery, red-orange marked lines (Figure 27) were found in all 
defects of all groups with a grade between 1 and 2. In the center they were only 
found with an incidence of 3/6 (group A), 5/6 (group B) and 4/5 (group C). 
Additionally to the defect area, there is also limited new bone formation at the 
endosteal area of the calvaria and around the vessels of the cortex (Figure 27). 






Figure 21: Microphotographs of 
calvarial defects of group A 
treated with collagen membrane 
and sorted cells (GE-stained, 
MMA-embedded thick-sections of 
the coronary plane through the 
defect center) 
Note the inter-individual variation in 
defect closure ranging from very 
low (animal 7 [right]) up to nearly 
complete (animal #9 [right]). Newly 
formed bone does not the reach 
the thickness of the preoperative 
state (for easier comparison of the 
defects the midline is always 
shown at left side of the picture, 
images of right-sided defect are 





Figure 22: Microphotographs of 
calvarial defects of group B 
treated with unsorted cells on a 
collagen membrane (GE- stained, 
MMA-embedded thick-sections of 
the coronary plane through the 
defect center).  
Note the inter-individual variation in 
defect closure ranging from very 
low (animal # 3 [right]) up to nearly 
complete (animal #1 [left]). 
Additionally, the newly formed 
bone does not the reach the 
thickness of the preoperative state. 
(for easier comparison of the 
defects the midline is always 
shown at left side of the picture, 
images of right-sided defect are 






Figure 23: Microphotographs of 
calvarial defects of group C 
treated with collagen membrane, 
only (GE- stained, MMA-
embedded thick-sections of the 
coronary plane through the defect 
center).  
Note the inter-individual variation in 
defect closure varies less in this 
group from moderate (animal # 1 
[right]) up to nearly complete 
(animal #1 [left]). The inter-
individual variation of the thickness 
of newly formed bone varies from 
very low (animal # 1 [right]) up to 
moderate (animal #7 [left]). 
However newly formed bone does 
not the reach the thickness of the 
preoperative state. (for easier 
comparison of the defects the 
midline is always shown at left side 
of the picture, images of right-sided 
defect are mirrored, # = animal #, 




Figure 24: Microphotographs showing morphological features of the new bone formation (GE-
stained slide of the left defect of animal # 1 [group B]). Note the general absence of cartilage tissue 
which characterizes the intra-membranous osteogenesis typical for calvarial bone. A: Overview (20x) 
shows the lateral aspect of the calvarial defect. The surgical cutting line is clear visible as is the 
difference in calvarial thickness (compare new bone [left] versus pre-existing bone [right]. Blood 
vessels are more frequent in the newly formed bone compared to the pre-existing calvarial bone (open 
white arrow heads) and hemosiderin (asterisks) in soft tissue above the newly formed bone, bar 200 
µm. B: Detail (40x) of the newly formed bone with osteoblasts lining on it (open black arrow heads), 
bar 100 µm. C: Detail (40x) of the border between newly formed and existing bone (arrows: cutting 
line). The differences in the shade of the bone's pink staining is caused by the degree of calcification 








Figure 25: Microphotograph of the central defect area (GE-stained slide of the right defect of 
animal # 5 [group C]). A: Overview (40x) showing the difference between newly formed bone and the 
degraded collagen membrane (open white arrow heads), bar 50 µm B: Detail (100x, oil) of darker pink 
stained newly formed bone with cells (black arrows), bar 20 µm C: Detail (100x, oil) of light pink, 







Figure 26: Overview-Microphotographs of the calvarial defect under epifluorescence (unstained 
slide, Xylenol Orange application at three weeks) animal # 1, left defect [group B]). A: Blue fluorescence 
caused by auto-fluorescence of bone and connective tissue. B: The red fluorescence is caused by 
incorporation of XO and shows the bone formation (and remodeling) at the time point three weeks post 









Figure 27: Microphotographs of the new bone formation at the lateral edge of the calvarial 
defect investigated under epifluorescence (unstained slide, XO application at three weeks, sample 
of animal # 3, left defect [group C]). A and B: Note the bright red line in the newly formed bone area 
(yellow arrow head) formed in continuity onto the pre-existing calvarial bone (green arrow head) 
without cartilaginous precursor tissue (intra-membranous osteogenesis). This line is caused by binding 
of the bone-seeking dye (XO) on Ca-ions in the matrix during new bone formation at timepoint three 
weeks post OP. Be aware, that even after timepoint three weeks post OP the bone formation is still 
ongoing (red arrow head in A / blue arrow head in B marks the bone at necropsy: four weeks post 
OP). Additionally to the defect area, there is also limited new bone formation at the endosteal area of 
the calvaria (white arrow head; growth related thickening), and around the vessels of the cortex 








Additionally to the three groups, one defect of animal # 11 (right side) was left empty 
(no membrane and no cells). In the histological analysis this defect showed a very 
low defect closure (grade 1). Only directly at the edge of the drill hole some new bone 
was formed, but not in the center of the defect. No vascularization could be found in 
this small amount of new formed bone, as well as no necrosis. Slight granulomatous 
inflammation was observed especially around suture material remnants. 
Since no new bone was formed in the center of the defect, a red-orange fluorescence 
signal could be observed only in the periphery and not in the center. 
 
Figure 28: Calvarial defect of the empty defect without treatment. Note the very low defect closure 
ranging in this defect. (GE- stained, MMA-embedded thick-sections of the coronary plane through the 
defect center; for easier comparison of the defects the midline is always shown at left side of the 






In this study, the effects on bone healing of sorted hBMSCs based on their 
Runx2/Sox9 ratio was investigated. Based on in vitro experiments, the hypothesis 
was that the sorted cells lead to more newly formed bone during bone healing of 
calvarial defects in nude rats than unsorted cells.  
After four weeks all animals were at an advanced state of defect closure. The fact 
that the newly formed bone was still relatively thin and not yet reaching the original 
thickness of the calvarial bone shows that the defect closure was not yet finished. 
This is supported by the degree of vascularization of the new bone which is still 
higher than in the adjacent non-defect area. In approx. 35% of the samples 
membrane remnants could still be detected in the histological analysis which 
supports the assumption of ongoing formation and remodeling. 
These findings are supported by the results of the fluorochrome marker Xylenol 
Orange (XO) showing red-orange marked lines not only in the periphery but also in 
the center of the defect. The red fluorescence line is caused by binding of the bone-
seeking dye (XO) on Ca-ions in the matrix during new bone formation and shows the 
bone formation and remodeling at timepoint three weeks post OP. This means defect 
closure was already advanced at an early time point. New bone was formed without 
cartilaginous precursor tissue which characterizes the intra-membranous 
osteogenesis typical for calvarial bone. 
However, the results of the CT evaluation showed no differences between sorted or 
unsorted cells. Interestingly, in the defects with membrane only more new bone was 
formed than in defects with membranes and cells. However, this was not statistically 
significant. The same result was observed for the defect closure in the histological 
examination. 
Hence, these results did not support our hypothesis, that hBMSCs sorted based on 
their Runx2 to Sox9 ratio lead to more newly formed bone than unsorted cells in 
calvarial defects in nude rats. Even more, seeded cells had a negative impact on the 
amount of newly bone formed compared with the membrane only group. This is in 
contrast to previous publications such as Suenaga et al, who demonstrated that in 
nude rats hBMSCs spheroids implanted in calvarial defects lead to significantly better 
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bone regeneration than β-tricalcium phosphate (β-TCP) granules or a combination of 
hBMSCs and β-TCP. The hBMSCs spheroids were generated without the use of 
artificial materials or scaffolds.29 Significantly better bone healing was also reported 
by Agacayak et al in rat calvarial defects treated with rat MSCs and platelet rich 
plasma (PRP) combined with synthetic biphasic calcium phosphate (BCP). This 
treatment showed the best healing compared to BCP alone, BCP plus PRP and BCP 
plus MSCs. With the combination of BCP plus MSCs the second-best healing was 
observed.30 Thus, in this study it was shown that both MSCs and PRP played a 
crucial role in improving bone healing and lead to a better healing of the defects. 
However, in our study the defect closure analyzed by CT and histologically show that 
neither the sorted nor the unsorted cells have an impact on bone healing.  
The above mentioned difference between the control group and the two groups with 
cells is even more obvious after two weeks. It is noticeable that less new bone was 
formed in group A and B compared to group C in the first two weeks after surgery. In 
the period between two and four weeks, approximately the same amount of new 
bone volume was formed in all three groups and the initially reduced bone formation 
in group A and B could be (partly) regained. 
Based on this observation it can be hypothesized that the sorted and unsorted 
hBMSCs (group A and B) initially impair bone healing. If the cells are no longer 
present in the defect after two weeks, these defects can heal with the same amount 
of newly formed bone as the defects of the control group (group C). One possible 
explanation for this impairment could be an inflammation reaction against the cells. 
This could lead to an early degradation of the cells as well as the membrane. After 
degradation of the cells the bone ingrowth could start. 
Nude rats should actually not trigger an inflammation reaction on human cells by their 
T-cell deficiency. This is the result of only a rudimentary thymic tissue.31 However, 
this cannot be ruled out, since nude rats can develop T-like cells with increasing 
age.32 In the study of Suenaga et al younger (seven compared to thirteen to 
seventeen week old used in this study) nude rats were used as recipient animals for 
the implantation of hBMSCs.29 
Nevertheless, the innate immune system could be activated by the hBMSCs, this 
could lead to an inflammation with activity of phagocytes such as macrophages and 
51 
 
neutrophils. Furthermore, it is known that athymic rats have an increased activity of 
natural killer (NK) cells.33, 34 Various authors describe, that NK cells play a major role 
in rejection of xenografts.35–38 Thus, in this study the NK cells could also be 
responsible for a rejection of the hBMSCs used as a xenograft. Further studies would 
be needed to determine the exact role of NK cells in this model. 
Based on the white blood cell count it cannot be concluded that the surgery led to a 
systemic inflammation. Therefore, at least two weeks after surgery, no systemic 
response to the membrane and cells was detectable. Nevertheless, a systemic 
inflammation may have occurred at a more recent time so that no changes in the 
blood value could be observed at the time of two weeks after surgery. Therefore, 
blood values of especially earlier time points would be needed. 
To be able to prove this, a study with a shorter observation period could be 
performed, to determine histologically the period during which the cells are detectable 
in the defect and whether they trigger an inflammation. 
Interestingly, most of the animals of the control group could largely bridge the defect. 
This reflects a high healing capacity of this animal species and shows the positive 
biological properties of the collagen membrane. The membrane itself appears to 
have a positive effect on bone healing, since in this study four out of five defects of 
the control group (group C) were mostly completely closed and these five millimeter 
defects are considered to be of critical size (see below for more details on critical size 
defect). Brunel et al and Song et al reported similar results. In their studies calvarial 
defects in rats filled with different collagen membranes healed better than empty 
defects.39, 40 Based on the histological assessment, the membrane in group C seem 
to serve as a guiding structure. Bone ingrowth can take place along this path. 
Histologically it was shown that the intrinsic characteristics of the membrane 
facilitated bone formation directly on its surface (osteoconduction), and led also to 
partly incorporation (osteointegration). The low grade of both osteonecrosis and 
inflammation of adjacent soft tissue characterizes the high tissue compatibility of the 
membrane. 
The membrane used in this study was a chemically non-crosslinked collagen I 
scaffold. Schmidt et al demonstrated in vitro that hMSCs seeded on the same 
collagen I membrane used in our study differentiated in osteogenic medium into 
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osteogenic lineage. This was shown due to their calcium phosphate mineralization. 
Without osteogenic medium no calcification could be seen. Also the membrane alone 
without cells but in osteogenic medium showed no mineralization.41 In this study, 
comparing to the empty defect, the scaffold seems to promote the formation of new 
bone in vivo. However, this data is definitely only preliminary due to the low number 
of animals. 
In six out of 17 defects light pink acellular material was observed. Due to its structure, 
it was defined as membrane remnants. As known from the observation of 
Rahmanian-Schwarz et al this membrane has a high biocompatibility and completely 
degrades 42 days after subcutaneous implantation in a rat model. Already 21 days 
after implantation only small residues could be noticed. No signs of wound healing 
disorders or inflammatory reaction could be observed.42 With an observation period 
of 28 days in the available study these results match with the findings of Rahmanian-
Schwarz et al. However, it would be an advantageous if further data on the 
degradation of the membrane in the calvarial defect model would be available. For 
this, the membranes without cells should be inserted into a calvarial defect and 
histological examinations should be carried out at earlier time points. 
The surgery method was chosen based on descriptions by Spicer et al 20 and 
Cooper, Mooney et al .43 Although it was not possible to drill all defects symmetrically 
round, this should not affect the calculation of the results. Through the post-surgery 
CT, the bone already present in the defect was excluded for further calculations. 
Various authors describe that the dura plays an important role in the healing of 
calvarial bone defects.20, 43, 44 Hobar et al demonstrated in guinea pigs that defects, 
filled with autologous bone, healed much better with greater osteoblastic numbers 
and osteoid activity when the dura was preserved compared to defects where the 
dura was resected. This observation was made both in immature and in mature 
animals.45 Wang and Glimcher showed that the osteoblasts involved in calvarial bone 
defect healing were initially derived from undifferentiated MSCs of the dura.46 In 
addition, it is hypothesized that the cerebrospinal fluid, which penetrates into the 
defects with an injury to the dura mater, could reduce or prevent the ossification. In 
summary, the dura mater plays an important role in healing of calvarial defects. 
Therefore, the goal of the surgical procedure was to avoid damage to the dura mater. 
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However, in three defects, the dura was injured, causing holes in the dura of about 
one Millimeter. In these defects, the smallest bone volume could be observed after 
four weeks compared to the other animals from the respective group. This difference 
was even more pronounced at two weeks. Thus, these results also show that the 
dura has a decisive influence on the healing of rat calvarial bone defects. If the 
defects with an injured dura mater are excluded from the evaluation, the differences 
between the groups increase, most likely reaching statistical significance. 
Furthermore it is possible that in addition to the macroscopically visible dura mater 
defects, other non-visible lesions of the dura mater have been created which 
negatively affect healing. This could be the case, for example, when lifting the bone 
piece from the defect. Adhesions of the endost with the dura mater could be the 
cause in this case. The presence of non-visible dura mater defects could be a reason 
for the uneven distribution of the results in each group. In order to prevent the injuries 
of the dura mater, it would be possible to change the surgery method. There are 
perforators (Acra-Cut®, USA) available specially designed for perforating the cranium. 
The perforators can be connected to an ANSPACH® high speed electric system 
(DePuy Synthes, Switzerland). These instruments are commonly used in 
neurosurgery to perforate the cranium. In contrast to the trephine technique, the 
perforator is designed to automatically disengage once perforation is accomplished 
and when pressure is removed from the drill point. In consequence, no dura mater 
and brain injuries should be observed. We tried this method beforehand in a cadaver 
study but unfortunately the thickness of the rat skull is not thick enough. A minimum 
thickness of two mm is specified by the manufacturer for the five mm perforator. 
Schmitz and Hollinger first defined in 1986 the critical size defect as “the smallest 
size intraosseous wound in a particular bone and species of animal that will not heal 
spontaneously during the lifetime of the animal”47. The critical size depends on the 
animal species, age, size and surgical technic (suturing the periosteum or not, dura 
mater preservation or injury). Bosch et al evaluated the critical size defect in the 
craniofacial region in five to six months old Wistar rats and defined a five mm 
calvarial defect as a critical size bone defect which heals by fibrous connective tissue 
formation. None of the untreated defects healed in this study and only connective 
tissue was present in the defects after twelve months.22 Although we used younger 
animals in our study, they were also skeletally mature. Preliminary data of the 
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additional operated empty defect (animal # 11, right defect) showed that much less 
new bone was formed in this defect than in all other defects of group A, B and C. 
Even if this is only a single defect, it can be assumed that our defects were critical 
size defects. To support this hypothesis, it would be useful to have further data of 
more empty defects. 
To avoid stress for the animal the rats have been accustomed to being handled and 
to any equipment used about four weeks prior to surgery. Based on the score and 
the weights it can be assumed that the burden of the animals is higher during the first 
week after surgery compared to the weeks two to four post op. However, the animals 
recovered very well and after one week post-surgery they all gained weight again. 
Over all the burden of the animals can be classified as moderate during the first week 
after surgery and as low from the second week on. 
The limitations of this study are the small number of animals per group which were 
operated. In addition, the numbers of animals per group were unequal. 
In order to achieve a statistical significance with the present non-normal distribution 
of the results, 17 defects per group would be required to determine after two weeks a 
difference with a probability of 80%. For a 90% probability, 22 defects would be 
needed. Since the difference was even lower after four weeks, even more defects per 
group would be needed at this time for a statistical significance. However, the clinical 
relevance of such data is questionable. With all the effort required for the cell sorting, 
a clear effect would be required. Since very clear differences in the groups have been 
shown in the in vitro experiments, the aim of this study was to prove this in vivo. If the 
in vivo study had shown similar results as the in vitro study, the group size would 
have been sufficient and a clear clinical relevance could be derived from these data. 
A further limit of the study was the use of only one bone marrow donor. To generate 
more meaningful data, it would be necessary to investigate stem cells from different 
donors to rule out donor dependent effects. 
One potential limitation of the study in the histological examination is the use of only 
one slice per defect for the histological analysis. In addition, the slice represents only 
a small part of the defect. Thus, changes like for example a possible dura mater 
injury, cannot be detected in a single histological slice if the injuries are not located in 
the incision plane but more rostral or caudal. Moreover, the histological examination 
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was only semi-quantitatively graded, additionally defect closure was estimated 
without absolute measurement of new formed bone. However, quantitative 
measurement by histomorphometry was not considered to be of additional value 
since the CT results could be used to calculate precise values of newly formed bone. 
To investigate why the defects filled with sorted as well as unsorted cells on a 
membrane did not have an effect on bone healing compared to defects filled with 
only the membrane further studies are necessary. To be able to identify an 
inflammatory or immune reaction, histology data from earlier times would be 
necessary. Seven to ten days after surgery could be an appropriate time to detect 
macrophages histologically for example, since at this time the macrophages should 
be predominant in the tissue, as various authors described.48–51 
In addition, more data regarding the healing of empty defects would also aim 
interpretation. This would be useful to prove the hypothesis that the membrane alone 
has a positive influence on bone healing. It would also be interesting to see whether 
two empty defects in the same animal show a similar healing or whether there are 
already differences within the animals. 
Another point that could have had an influence is the cell culture procedure. Only the 
sorted cells were induced in osteogenic medium for one week whereas the unsorted 
cells were only cultured in growth medium. This was done in order to be able to 
compare the data with other studies, since normally uninduced cells are used. 
However, the induction of the sorted cells was necessary to be able to sort the cells 
afterwards. If the sorted cells had a markedly positive effect on the amount of the 
new bone formed, further studies would have been necessary. For example, a 




In summary, the hypothesis that hBMSCs sorted based on their Runx2 to Sox9 ratio 
lead to more newly formed bone than unsorted cells in calvarial defects in nude rats 
could not be confirmed in the present study. In the defects with membrane only more 
new bone was formed than in defects with membranes and sorted or unsorted cells. 
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Nevertheless, neither in the CT nor in the histological analysis significant differences 
could be found. Further studies are needed to determine how long the cells are 
present in the defect and how they hinder bone healing. 
The membrane itself appears to have positive effects on bone healing in terms of 
osteoconduction and osteointegration, if it is assumed that these five mm defects are 
critical size defects. However, a larger number of defects with membrane only and a 
comparison to empty defects would be necessary. 
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7 Attachments  
 
Group allocation 
Table 10: Group allocation, *: This animal died during anesthesia before surgery 
Animal # Left defect filled with group Right defect filled with group 
0 NA* NA* 
1 B C 
2 C B 
3 C B 
4 A B 
5 A C 
6 B A 
7 C A 
8 A B 
9 B A 
10 C A 














Health monitoring: PCR Rodent Infectious Agent Test 
 





Micro computed tomography data: 





Bone Volume [mm3] 
Individual Average ± standard deviation 
post OP 2 weeks 4 weeks post OP 2 weeks 4 weeks 
A 






5 L 0.000 0.348 1.179 
6 R 0.000 0.477 2.770 
7 R 0.000 0.389 1.361 
8 L 0.000 0.407 1.586 
9 R 0.000 0.878 2.576 
B 






3 R 0.000 0.515 1.528 
4 R 0.000 0.341 2.053 
6 L 0.000 0.573 1.930 
8 R 0.000 0.210 0.824 
9 L 0.000 0.764 2.544 
C 






3 L 0.000 1.069 3.044 
5 R 0.000 0.957 2.307 
7 L 0.000 1.351 3.489 
11 L 0.000 0.385 2.220 




Micro computed tomography images post OP: 



























































































































































































Figure 32: CT images post OP, rostral: always shown at top of the picture 
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Micro computed tomography images 2 weeks post OP 



























































































































































































Figure 33: CT images 2 weeks post OP, rostral: always shown at top of the picture 
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Micro computed tomography images 4 weeks post OP 



























































































































































































Figure 34: CT images 4 weeks post OP, rostral: always shown at top of the picture 
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Table 12: Histological grading 
Grade Grading general Grading defect closure 
1 minimal 1-20 % 
2 slight -40 % 
3 moderate -60 % 
4 marked -80 % 
5 massive -100% 
Table 13: Grading of metal remnants: 
Grade Grading metal remnants 








Location (L/R) L L R R L R L R R L R L R L R L L R
Animal No 4 5 6 7 8 9 1 3 4 6 8 9 1 3 5 7 11 11
Histo No (GE) 27217/18 27218/07 27219/12 27220/09 27221/14 27222/09 27215/12 27216/14 27217/13 27219/18 27221/08 27222/12 27215/5 27216/11 27218/05 27220/15 27227/12 27227/6 
remarks fascia
[0/P] 0 0 0 0 0 0 0 P 0 P 0 0 0 0 0 0 0 0
remarks subdural
[grade 1-5] 1 2 1 2 0 1 2 1 2 2 0 2 1 2 2 1 2 0
remarks fascia

















[grade 1-5] 0 1 1 1 1 1 0 1 1 1 1 1 0 1 1 1 3 2
STDEV
mean [in %]
in %, [estimated] 21 55 95 15 45 95 98 20 75 45 5 85 50 90 90 90 90 5
mean 1.0
[grade 1-5] 2 3 5 1 3 5 5 1 4 3 1 5 3 5 5 5 5 1
mean
[grade 1-5] 2 3 3 1 1 2 3 2 2 2 1 3 1 3 3 3 3 0
mean
[grade 1-5] 1 3 4 0 2 3 2 2 2 1 0 3 1 3 3 3 3 0
mean
[grade 1-5] 2 0 0 0 1 0 0 0 0 0 1 0 2 2 0 1 0 0
mean
[grade 1-5] 1 3 1 1 2 2 1 0 3 1 1 3 3 1 3 3 3 0
[grade 1-5] - 3 1 - - - 1 - - - - 2 - 2 3 2 - -
Histo No (FL) 27217/17 27218/06 27219/11 27220/08 27221/15 27222/10 27215/13 27216/15 27217/14 27219/17 27221/07 27222/13 27215/6 27216/10 27218/06 27220/16 27227/11 27227/04
mean
[grade 1-5] 2 2 2 1 2 2 1 2 2 2 1 2 1 2 1 2 2 1
mean
[grade 1-5] 0 1 2 0 0 2 1 1 1 1 0 2 0 1 2 2 2 0
1.8 1.7 1.6
1.41.00.8
light pink, acellular material 
(membrane remnants) 
red FL signal (xylenol orange), periphery 
(filter set 25)
red FL signal (xylenol orange), central 
(filter set 25)
defect closure by new bone [grade 1-5, 
see above %]
thickness of new calvarial bone 
vascularization, of new calvarial bone 
necrosis, of new calvarial bone (empty 
lacunae) 
brown finegranular material
(degraded collagen membrane ?)
metal remnants
hemosiderin, soft tissue, near defect 
inflammation, lymphocytic, soft tissue 
inflammation, granulom., soft tissue 
defect closure by new bone, in %, 
[estimated]
A B C












Factor treatment (groups): 
Table 15: Statistical values of the influence of the factor treatment (groups) 
Parameter Value p-value 
CT 
Bone volume after 2 weeks 1.12 0.57 
Bone volume after 4 weeks 1.35 0.51 
Inferred bone growth 1.06 0.59 
Histology 
Defect closure 1.71 0.43 
Thickness 1.78 0.41 




Table 16: Statistical values of the influence of the factor time 
Parameter Chi p 
Bone volume measured with CT 21.144 <0.05 




8 List of Abbreviations 
BW   Bodyweight 
CT   Computed tomography 
EDTA   Ethylenediaminetetraacetic acid 
ESCs   Embryonic stem cells 
FACS   Fluorescence activated cell sorting 
FL   Fluorescence 
GE   Giemsa eosin 
h   hour 
HIV   Human immunodeficiency virus 
kg   Kilogram 
IVC   Individually ventilated cages 
hBMSCs  Human bone marrow mesenchymal stem cells 
mg   Milligram 
ml   Milliliter 
MMA   Methyl Methacrylate 
MSCs   Mesenchymal stem cells 
NaCl   Sodium chloride 
OP   Operation 
ROI   Region of interest 
rpm   revolutions per minute 
s.c.   subcutaneously 
SD   Standard deviation 
SPF   Specific pathogen free 
VOI   Volume of interest 
WBC   White blood cells 
XO   Xylenol Orange 
µCT   Micro computed tomography 
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